Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 3 of about 3   

Articles published

NVS 104.28 -1.22 (-1.16%)
price chart
Basic patent and SPC � what do they actually cover?
Novartis AG had requested injunctive relief against Actavis Deutschland GmbH & Co. KG, enjoining them from distributing a generic combination medicament containing the active ingredients Valsartan and Hydrochlorothiazide (HCTZ1) for the treatment of ...
Related articles »  
New pharmacovigilance system debuts in EU
New rules governing the monitoring, identification and assessment of adverse events caused by pharmaceuticals are introduced, with the aim of making the EU-wide system for overseeing drug safety and 'benefit-risk' more transparent and robust.
Related articles »  
Roche Building On Its Strengths
... in Europe. Overall profitability was okay. Core operating profit rose about 5%, with solid 7% growth in pharmaceuticals and a 6% decline in diagnostics due to bad debt expense in emerging markets and an elevated level of system placements (which ...